Structure Therapeutics (GPCR) Other financing activities (2022 - 2026)

Structure Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $869000.0 for Q1 2026.

• On a quarterly basis, Other financing activities fell 9.95% year-over-year to $869000.0 in Q1 2026; TTM through Mar 2026 was $4.4 million, a 114.58% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 144.07% from the prior year.
• Other financing activities eased to $869000.0 in Q1 2026 per GPCR's latest filing, from $4.1 million in the prior quarter.
• Across five years, Other financing activities topped out at $172.3 million in Q1 2023 and bottomed at -$172.1 million in Q2 2023.
• The 5-year median for Other financing activities is $616500.0 (2024), against an average of $21.9 million.
• Across the five-year window, Other financing activities jumped 593300.0% in 2023 and slumped 234.51% in 2025, its largest moves.
• Year by year, Other financing activities stood at $29000.0 in 2022, then surged by 440258.62% to $127.7 million in 2023, then slumped by 99.82% to $224000.0 in 2024, then soared by 1708.48% to $4.1 million in 2025, then sank by 78.55% to $869000.0 in 2026.
• Per Business Quant, the three latest GPCR Other financing activities figures stand at $869000.0 (Q1 2026), $4.1 million (Q4 2025), and -$534000.0 (Q3 2025).